Nexalin Technology Inc
NASDAQ:NXL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Nexalin Technology Inc
NASDAQ:NXL
|
US |
|
R
|
Rebase Inc
TSE:5138
|
JP |
|
A
|
Addi Industries Ltd
BSE:507852
|
IN |
|
Sanko Pazarlama Ithalat Ihracat AS
IST:SANKO.E
|
TR |
|
Ganesh Benzoplast Ltd
NSE:GANESHBE
|
IN |
|
S H Kelkar and Company Ltd
NSE:SHK
|
IN |
|
S
|
Saudi Industrial Export Company SJSC
SAU:4140
|
SA |
Nexalin Technology Inc
Nexalin Technology, Inc. designs and develops neurostimulation products. The company is headquartered in Laguna Niguel, California and currently employs 2 full-time employees. The company went IPO on 2022-09-16. The firm developed an easy-to-administer medical device, Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. The company is also designing clinical trials for the use of Gen-2 for the treatment of substance use disorders and particularly substance abuse issues related to opiates, chronic pain, Alzheimer’s disease and dementia. The firm's products are non-invasive and undetectable and can provide relief to those afflicted with mental health issues without adverse side effects. Its design of varying voltages, currents, electromagnetic fields and various frequencies called as waveform. Its devices generate a high frequency, charge balanced electrical current waveform that is applied to an array of electrodes on the head.
Nexalin Technology, Inc. designs and develops neurostimulation products. The company is headquartered in Laguna Niguel, California and currently employs 2 full-time employees. The company went IPO on 2022-09-16. The firm developed an easy-to-administer medical device, Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. The company is also designing clinical trials for the use of Gen-2 for the treatment of substance use disorders and particularly substance abuse issues related to opiates, chronic pain, Alzheimer’s disease and dementia. The firm's products are non-invasive and undetectable and can provide relief to those afflicted with mental health issues without adverse side effects. Its design of varying voltages, currents, electromagnetic fields and various frequencies called as waveform. Its devices generate a high frequency, charge balanced electrical current waveform that is applied to an array of electrodes on the head.
